Granahan Investment Management LLC boosted its position in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 34.1% during the first quarter, HoldingsChannel.com reports. The fund owned 122,099 shares of the company’s stock after buying an additional 31,079 shares during the quarter. Granahan Investment Management LLC’s holdings in HealthEquity were worth $10,204,000 at the end of the most recent reporting period.
A number of other hedge funds have also added to or reduced their stakes in HQY. Public Employees Retirement System of Ohio lifted its stake in HealthEquity by 23.4% during the first quarter. Public Employees Retirement System of Ohio now owns 77,914 shares of the company’s stock worth $6,511,000 after purchasing an additional 14,777 shares during the last quarter. Keebeck Wealth Management boosted its holdings in shares of HealthEquity by 13.2% in the 1st quarter. Keebeck Wealth Management now owns 5,373 shares of the company’s stock valued at $449,000 after purchasing an additional 627 shares in the last quarter. State of Wyoming bought a new position in shares of HealthEquity in the 1st quarter valued at $866,000. Cetera Investment Advisers increased its stake in shares of HealthEquity by 1.2% in the 1st quarter. Cetera Investment Advisers now owns 26,251 shares of the company’s stock valued at $2,194,000 after purchasing an additional 308 shares during the last quarter. Finally, First Trust Advisors LP raised its holdings in shares of HealthEquity by 24.3% during the 1st quarter. First Trust Advisors LP now owns 38,086 shares of the company’s stock worth $3,183,000 after buying an additional 7,439 shares in the last quarter. 99.55% of the stock is owned by institutional investors.
HealthEquity Stock Up 0.3%
Shares of NASDAQ:HQY opened at $94.64 on Friday. The company has a fifty day moving average of $90.21 and a 200-day moving average of $84.94. The company has a market capitalization of $7.91 billion, a PE ratio of 35.45, a price-to-earnings-growth ratio of 1.59 and a beta of 0.21. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $105.96.
Insiders Place Their Bets
In other HealthEquity news, EVP Delano Ladd sold 7,500 shares of the stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $675,000.00. Following the completion of the transaction, the executive vice president directly owned 91,141 shares in the company, valued at approximately $8,202,690. This trade represents a 7.60% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of HealthEquity stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $219,510.00. Following the sale, the director directly owned 19,733 shares in the company, valued at $1,775,970. The trade was a 11.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 17,905 shares of company stock valued at $1,651,280 in the last 90 days. Corporate insiders own 1.60% of the company’s stock.
Analyst Ratings Changes
Several analysts recently weighed in on HQY shares. Citigroup restated a “market outperform” rating on shares of HealthEquity in a research report on Monday, June 1st. KeyCorp reiterated an “overweight” rating on shares of HealthEquity in a research report on Tuesday, May 26th. Wells Fargo & Company set a $111.00 target price on HealthEquity in a research note on Monday, June 1st. BMO Capital Markets raised shares of HealthEquity from a “market perform” rating to an “outperform” rating and increased their target price for the stock from $85.00 to $105.00 in a report on Thursday, April 9th. Finally, Wall Street Zen upgraded shares of HealthEquity from a “hold” rating to a “buy” rating in a research note on Saturday. Eleven investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $110.93.
Get Our Latest Stock Report on HQY
About HealthEquity
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
See Also
- Five stocks we like better than HealthEquity
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
